search
Back to results

Effect of Regulated Add -on Sodium Chloride Intake on Stabilization of Serum Lithium Concentration in Bipolar Disorder

Primary Purpose

Bipolar Affective Disorder

Status
Completed
Phase
Phase 4
Locations
India
Study Type
Interventional
Intervention
Lithium Carbonate
Sodium chloride
Sponsored by
All India Institute of Medical Sciences, Bhubaneswar
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Bipolar Affective Disorder focused on measuring Bipolar affective disorder, Lithium, Manic depressive psychosis, Sodium chloride

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients aged 18 -60 years, of either sex with the clinical diagnosis of bipolar disorder (DSM V) who are on maintenance lithium therapy for ≥ 1month and ≤ 6 months.
  • Patients with normal serum sodium level (135 -145 mEq/L) and serum lithium in the optimum therapeutic range (<0.6 mEq/ L or >0.8 mEq/ L) .

Exclusion Criteria:

  • Patients with comorbidities like other psychiatric disorder s, organicity, substance abuse, personality disorder, intellectual disability and other neurotic disorders .
  • Patients with any renal, cardiovascular, neurologica l, endocrinal and hepatic dysfunction.
  • Patients suffering from diarrhoea, dehydration
  • History of any invasive neurosurgical/ non -invasive neuropsychiatric procedure.
  • Medication history of psychoactive or central nervous system depressant drugs.
  • Patients who are on NSAIDs, ACE inhibitors, antiarrhythmics, diuretics and neuromuscular blocking agents .
  • Pregnant and nursing women .
  • Patients with drug/alcohol abuse.

Sites / Locations

  • Aiims Bhubaneswar

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Lithium carbonate

Add-on Sodium chloride

Arm Description

Lithium carbonate is prescribed 800-900 mg per day for 12 weeks.

Sodium chloride 1gm per day per will be prescribed along with Lithium carbonate 800-900 mg per day for 12 weeks.

Outcomes

Primary Outcome Measures

Difference in percentage of bipolar patients showing fluctuation in serum lithium level
Serum lithium level will be done by electrolyte analyzer. The patients showing fluctuations ( fluctuation is defined as serum lithium <0.6 mEq/ L or >0.8 mEq/ L in maintenance phase) in serum lithium level between the groups over 12 weeks.

Secondary Outcome Measures

Serum sodium
Will be done by electrolyte analyzer.
Serum Potassium
Will be done by electrolyte analyzer.
Serum creatinine
Will be done by autoanalyser.
Serum aldosterone
Will be done by commercially available ELISA kit.
ECG changes
ECG changes for lithium toxicity (T wave inversion, PR prolongation, QT prolongation), hyponatremia (P wave alterations), hypernatremia (short PR interval and diffuse ST depression) will be looked for
Serum Lithium
Will be done by electrolyte analyzer.

Full Information

First Posted
January 7, 2020
Last Updated
January 24, 2022
Sponsor
All India Institute of Medical Sciences, Bhubaneswar
search

1. Study Identification

Unique Protocol Identification Number
NCT04222816
Brief Title
Effect of Regulated Add -on Sodium Chloride Intake on Stabilization of Serum Lithium Concentration in Bipolar Disorder
Official Title
Effect of Regulated Add -on Sodium Chloride Intake on Stabilization of Serum Lithium Concentration in Bipolar Disorder: A Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
January 2022
Overall Recruitment Status
Completed
Study Start Date
January 16, 2020 (Actual)
Primary Completion Date
December 31, 2021 (Actual)
Study Completion Date
January 7, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
All India Institute of Medical Sciences, Bhubaneswar

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Bipolar affective disorder or manic -depressive psychosis (MDP) is a mood disorder affecting 2.4% of the global population . Lithium is considered as the "gold standard" for the treatment of bipolar disorder but the clinical use of lithium is often restricted due to its narrow therapeutic range and adverse effects. In a published case report, Bleiwiss H found that sodium chloride supplementation diminished the adverse effects caused by lithium The literature search also revealed that till date, there is no published clinical study evaluating the effect of dietary intake of sodium in preventing the fluctuations of serum lithium level and lithium toxicity Therefore, a randomized clinical trial has been designed to evaluate the effect of regulated add -on dietary sodium chloride on serum lithium levels in bipolar disorder.
Detailed Description
Bipolar affective disorder or manic -depressive psychosis (MDP) is a mood disorder affecting 2.4% of the global population. Lithium is considered as the "gold standard" for the treatment of bipolar disorder but the clinical use of lithium is often restricted due to its narrow therapeutic range and adverse effects.One of the major adverse effects of lithium is nephrogenic diabetes insipidus which is due to long -term renal dysfunction. In the initial months of lithium therapy, psychiatrists face difficulty in titrating the dose and stabilizing serum lithium level and this fluctuation of serum lithium level may be due to a lithium-induced sodium depleted state. In a published case report, Bleiwiss H found that sodium chloride supplementation diminished the adverse effects caused by lithium. 8 In another case report, Tomita et al demonstrated that the change in sodium chloride intake can bring about changes in serum lithium and help in stabilizing the levels of serum lithium concentration. As all the case reports are from abroad, the effect of dietary sodium on serum lithium level among Indian population is completely unknown. The literature search also revealed that till date, there is no published clinical study evaluating the effect of dietary intake of sodium in preventing the fluctuations of serum lithium level and lithium toxicity. Therefore, a randomized clinical trial has been designed to evaluate the effect of regulated add -on dietary sodium chloride on serum lithium levels in bipolar disorder. This study may help to explore the role of add -on sodium chloride in decreasing the fluctuations in the serum lithium level and improving the clinical outcome of patients with bipolar disorders.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bipolar Affective Disorder
Keywords
Bipolar affective disorder, Lithium, Manic depressive psychosis, Sodium chloride

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Model Description
Randomized, open label, parallel group, active controlled clinical trial
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Lithium carbonate
Arm Type
Active Comparator
Arm Description
Lithium carbonate is prescribed 800-900 mg per day for 12 weeks.
Arm Title
Add-on Sodium chloride
Arm Type
Experimental
Arm Description
Sodium chloride 1gm per day per will be prescribed along with Lithium carbonate 800-900 mg per day for 12 weeks.
Intervention Type
Drug
Intervention Name(s)
Lithium Carbonate
Intervention Description
Lithium carbonate 800-900 mg orally daily for 12 weeks
Intervention Type
Drug
Intervention Name(s)
Sodium chloride
Intervention Description
Sodium chloride 1gm daily per orally for 12 weeks
Primary Outcome Measure Information:
Title
Difference in percentage of bipolar patients showing fluctuation in serum lithium level
Description
Serum lithium level will be done by electrolyte analyzer. The patients showing fluctuations ( fluctuation is defined as serum lithium <0.6 mEq/ L or >0.8 mEq/ L in maintenance phase) in serum lithium level between the groups over 12 weeks.
Time Frame
12 weeks
Secondary Outcome Measure Information:
Title
Serum sodium
Description
Will be done by electrolyte analyzer.
Time Frame
12 weeks
Title
Serum Potassium
Description
Will be done by electrolyte analyzer.
Time Frame
12 weeks
Title
Serum creatinine
Description
Will be done by autoanalyser.
Time Frame
12 weeks
Title
Serum aldosterone
Description
Will be done by commercially available ELISA kit.
Time Frame
12 weeks
Title
ECG changes
Description
ECG changes for lithium toxicity (T wave inversion, PR prolongation, QT prolongation), hyponatremia (P wave alterations), hypernatremia (short PR interval and diffuse ST depression) will be looked for
Time Frame
12 weeks
Title
Serum Lithium
Description
Will be done by electrolyte analyzer.
Time Frame
12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients aged 18 -60 years, of either sex with the clinical diagnosis of bipolar disorder (DSM V) who are on maintenance lithium therapy for ≥ 1month and ≤ 6 months. Patients with normal serum sodium level (135 -145 mEq/L) and serum lithium in the optimum therapeutic range (<0.6 mEq/ L or >0.8 mEq/ L) . Exclusion Criteria: Patients with comorbidities like other psychiatric disorder s, organicity, substance abuse, personality disorder, intellectual disability and other neurotic disorders . Patients with any renal, cardiovascular, neurologica l, endocrinal and hepatic dysfunction. Patients suffering from diarrhoea, dehydration History of any invasive neurosurgical/ non -invasive neuropsychiatric procedure. Medication history of psychoactive or central nervous system depressant drugs. Patients who are on NSAIDs, ACE inhibitors, antiarrhythmics, diuretics and neuromuscular blocking agents . Pregnant and nursing women . Patients with drug/alcohol abuse.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
DEBASISH HOTA, DM
Organizational Affiliation
PROFESSOR AND HEAD OF THE DEPARTMENT
Official's Role
Study Director
Facility Information:
Facility Name
Aiims Bhubaneswar
City
Khorda
State/Province
Orissa
ZIP/Postal Code
751019
Country
India

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
21383262
Citation
Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, Viana MC, Andrade LH, Hu C, Karam EG, Ladea M, Medina-Mora ME, Ono Y, Posada-Villa J, Sagar R, Wells JE, Zarkov Z. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011 Mar;68(3):241-51. doi: 10.1001/archgenpsychiatry.2011.12.
Results Reference
background
PubMed Identifier
4189720
Citation
Bleiweiss H. Salts supplements with lithium. Lancet. 1970 Feb 21;1(7643):416. doi: 10.1016/s0140-6736(70)91550-3. No abstract available.
Results Reference
background
PubMed Identifier
26935095
Citation
Tomita T, Goto H, Sumiya K, Yoshida T, Tanaka K, Kohda Y. Stabilization of the Serum Lithium Concentration by Regulation of Sodium Chloride Intake: Case Report. Yakugaku Zasshi. 2016;136(3):517-21. doi: 10.1248/yakushi.15-00256.
Results Reference
background
PubMed Identifier
4949647
Citation
Demers RG, Heninger GR. Sodium intake and lithium treatment in mania. Am J Psychiatry. 1971 Jul;128(1):100-4. doi: 10.1176/ajp.128.1.100. No abstract available.
Results Reference
background
PubMed Identifier
31394485
Citation
Selvarajan S, Manohar H, Das S, Sakkarabani P, Kandasamy P. Lithium prophylaxis in early-onset Bipolar disorder: a descriptive study. Asian J Psychiatr. 2019 Aug;44:172-174. doi: 10.1016/j.ajp.2019.07.053. Epub 2019 Jul 30.
Results Reference
background
PubMed Identifier
28503106
Citation
Tondo L, Vazquez GH, Baldessarini RJ. Depression and Mania in Bipolar Disorder. Curr Neuropharmacol. 2017 Apr;15(3):353-358. doi: 10.2174/1570159X14666160606210811.
Results Reference
background
PubMed Identifier
21199968
Citation
Kessler RC, Ormel J, Petukhova M, McLaughlin KA, Green JG, Russo LJ, Stein DJ, Zaslavsky AM, Aguilar-Gaxiola S, Alonso J, Andrade L, Benjet C, de Girolamo G, de Graaf R, Demyttenaere K, Fayyad J, Haro JM, Hu Cy, Karam A, Lee S, Lepine JP, Matchsinger H, Mihaescu-Pintia C, Posada-Villa J, Sagar R, Ustun TB. Development of lifetime comorbidity in the World Health Organization world mental health surveys. Arch Gen Psychiatry. 2011 Jan;68(1):90-100. doi: 10.1001/archgenpsychiatry.2010.180.
Results Reference
background
PubMed Identifier
28529357
Citation
Murthy RS. National Mental Health Survey of India 2015-2016. Indian J Psychiatry. 2017 Jan-Mar;59(1):21-26. doi: 10.4103/psychiatry.IndianJPsychiatry_102_17. No abstract available.
Results Reference
background
PubMed Identifier
31579157
Citation
Mandal S, Mamidipalli SS, Mukherjee B, Hara SKH. Perspectives, attitude, and practice of lithium prescription among psychiatrists in India. Indian J Psychiatry. 2019 Sep-Oct;61(5):451-456. doi: 10.4103/psychiatry.IndianJPsychiatry_451_18.
Results Reference
background

Learn more about this trial

Effect of Regulated Add -on Sodium Chloride Intake on Stabilization of Serum Lithium Concentration in Bipolar Disorder

We'll reach out to this number within 24 hrs